Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05744960 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Financial Incentives

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Eligibility criteria expanded, about 16 words
  2. Re-verified, no change to tracked fieldsv8
  3. Primary completion date: Jul 31, 2025 to Apr 30, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Aug 31, 2026 to Aug 29, 2026
    • Site details revised
    v7
  4. 2 versions Re-verified since Dec 20, 2024, no change to tracked fieldsv5-v6
  5. Site contact updatedv4
  6. 2 versions Re-verified since Mar 15, 2023, no change to tracked fieldsv2-v3
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This trial will look at the impact of clinic-level financial incentives to improve provider communication and increase HPV vaccine uptake. Some clinics will receive communication training. Other clinics will receive the same training and a clinic-level financial incentive program with a monthly data feedback report to increase HPV vaccine uptake.
Trial Details
NCT Number NCT05744960
Lead Sponsor UNC Lineberger Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Human Papilloma Virus
Enrollment 34 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov